Newcastle University

The effective treatment of cancer depends on accurate targeting in order to avoid unacceptable side effects. In this seminar speakers will discuss the "state of the art" in the field of treatment stratification, including a Faculty Lecture given by Professor Salto-Tellez from Belfast on "The role of pathology in molecular diagnostics and stratified medicine".

To register please go to http://forms.ncl.ac.uk/view.php?id=4038  

  

Programme

1:30        Introduction- Professor Andy Hall, Director NICR

1:40        Quantitative and qualitative analyses of minimal residual disease in childhood

               acute lymphoblastic leukaemia- Dr Julie Irving

2:05        Treatment stratification in Chronic Lymphocytic Leukaemia- Dr Elaine Wilmore

2:30        The challenge of the whole genome- Professor Steve Clifford

2:55        Molecular Diagnostics in a Commercial Lab- Dr Ann Curtis

3:20        Identifying new targets in cancer- Professor Craig Robson

3:45        Turning drug targets into drugs- Professor Steve Wedge

4:10        Clinical trials in stratified medicine- Professor Ruth Plummer

4:35        Concluding remarks

4:45        Break

  

 

 

All staff and students are welcome so please come along.